CD4 T Cells Mediate Both Positive and Negative Regulation of the Immune Response to HIV Infection: Complex Role of T Follicular Helper Cells and Regulatory T Cells in Pathogenesis
Overview
Affiliations
HIV-1 infection results in chronic activation of cells in lymphoid tissue, including T cells, B-cells, and myeloid lineage cells. The resulting characteristic hyperplasia is an amalgam of proliferating host immune cells in the adaptive response, increased concentrations of innate response mediators due to viral and bacterial products, and homeostatic responses to inflammation. While it is generally thought that CD4 T cells are greatly depleted, in fact, two types of CD4 T cells appear to be increased, namely, regulatory T cells (Tregs) and T follicular helper cells (Tfh). These cells have opposing roles, but may both be important in the pathogenic process. Whether Tregs are failing in their role to limit lymphocyte activation is unclear, but there is no doubt now that Tfh are associated with B-cell hyperplasia and increased germinal center activity. Antiretroviral therapy may reduce the lymphocyte activation, but not completely, and therefore, there is a need for interventions that selectively enhance normal CD4 function without exacerbating Tfh, B-cell, or Treg dysfunction.
Cheng S, Wang H, Kang X, Zhang H Pharmaceutics. 2024; 16(2).
PMID: 38399305 PMC: 10892906. DOI: 10.3390/pharmaceutics16020251.
SARS-CoV-2 Portrayed against HIV: Contrary Viral Strategies in Similar Disguise.
Duerr R, Crosse K, Valero-Jimenez A, Dittmann M Microorganisms. 2021; 9(7).
PMID: 34198973 PMC: 8307803. DOI: 10.3390/microorganisms9071389.
Sharing CD4+ T Cell Loss: When COVID-19 and HIV Collide on Immune System.
Peng X, Ouyang J, Isnard S, Lin J, Fombuena B, Zhu B Front Immunol. 2021; 11:596631.
PMID: 33384690 PMC: 7770166. DOI: 10.3389/fimmu.2020.596631.
Roider J, Ngoepe A, Muenchhoff M, Adland E, Groll A, Ndungu T Front Immunol. 2019; 10:213.
PMID: 30809229 PMC: 6379343. DOI: 10.3389/fimmu.2019.00213.
Filaci G, Fenoglio D, Taramasso L, Indiveri F, Di Biagio A Front Immunol. 2018; 9:2447.
PMID: 30459765 PMC: 6232923. DOI: 10.3389/fimmu.2018.02447.